4//SEC Filing
Klassen Preston 4
Accession 0001209191-23-045630
CIK 0001505512other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:24 PM ET
Size
5.4 KB
Accession
0001209191-23-045630
Insider Transaction Report
Form 4
Klassen Preston
DirectorPresident & Head of R & D
Transactions
- Award
Stock Option (Right to Buy)
2023-08-10+225,000→ 225,000 totalExercise: $1.36Exp: 2033-08-09→ Common Stock (225,000 underlying)
Footnotes (1)
- [F1]The stock option will vest ratably on a monthly basis over a 48 month period subject to the reporting person's continuous service to Regulus through each such vesting date.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeother
Related Parties
1- filerCIK 0001493056
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 4:24 PM ET
- Size
- 5.4 KB